losing it makes maintaining weight loss harder Higher risk of weight regain: A lower metabolic rate makes stopping or reducing medication much riskier Reduced functional strength: Weakness, limited mobility, and increased fall risk are all linked to muscle loss Impaired blood sugar regulation: Muscle plays a direct role in how the body processes glucose after meals How to Preserve Muscle Mass on GLP-1 Medications Research shows that muscle loss during GLP-1 therapy is not inevitable
But Lilly appears to be gaining share on Novo even faster than we expected, says Morningstar Director of Healthcare Equity Research Karen Andersen
Semaglutide for weight management is typically administered as a once-weekly subcutaneous injection, given in the abdomen, thigh, or upper arm
however, Y1-R agonism may also stimulate a reaction step in the glycolytic pathway
Your individual response depends on baseline cholesterol levels, genetics, weight loss achieved, and adherence